Lung Cancer Clinical Trial

MRI and Biomarkers for Lung Nodules Detected During Lung Cancer Screening

Summary

The primary objective of this pilot observational study is to evaluate the accrual and retention rate of a study population from a centralized lung cancer screening program to support MRI and blood-based biomarker research for lung cancer screening.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Ability to read and understand informed consent
Male or female adults who are at high risk for lung cancer and are enrolled in the centralized lung cancer screening program: Based on USPSTF guidelines: Age 50-80 with 20 or greater pack-year smoking story who continue to smoke or quit within the past 15 years without sign or symptoms of lung cancer. Or based on National Comprehensive Cancer Network (NCCN) guidelines but do not meet the USPSTF guidelines, age 50-unlimited
Found to have one or more lung nodules that is 6mm or greater on screening LDCT

Exclusion Criteria:

Persons with an active diagnosis of cancer
Persons with active signs or symptoms of lung cancer
Persons with mechanically, magnetically, or electrically activated implants, such as cardiac pacemakers, neurostimulators, and infusion pumps.
Persons with ferromagnetic implants and ferromagnetic foreign bodies, such as intracranial aneurysm clips, shrapnel and intraocular metal chips as these could become dislodged.
Persons who are pregnant, nursing, are implanted with intrauterine devices (IUD's) that are not MR-compatible
Persons unable to tolerate MRI imaging secondary to an inability to lie supine or severe claustrophobia.
Persons who are non-compliant with visit instructions, including inability to lie still, hold breath or follow procedure instructions

Study is for people with:

Lung Cancer

Estimated Enrollment:

30

Study ID:

NCT05699213

Recruitment Status:

Recruiting

Sponsor:

Cedars-Sinai Medical Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Cedars-Sinai Medical Center
Los Angeles California, 90048, United States More Info
Weijia Chua, M.D.
Contact

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

30

Study ID:

NCT05699213

Recruitment Status:

Recruiting

Sponsor:


Cedars-Sinai Medical Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.